Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
Debt to Equity Over Time
Above historical average, strong compound growth.
Left:
||||
Debt-to-equity ratio
Latest
0.89
↑ 179% above average
Average (9y)
0.32
Historical baseline
Range
High:0.98
Low:0.11
CAGR
+22.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 0.89 | -8.9% |
| 2023 | 0.98 | +402.6% |
| 2022 | 0.19 | -17.4% |
| 2021 | 0.23 | +40.5% |
| 2020 | 0.17 | -4.3% |
| 2019 | 0.17 | +15.7% |
| 2018 | 0.15 | +8.1% |
| 2017 | 0.14 | +22.0% |
| 2016 | 0.11 | -17.6% |
| 2015 | 0.14 | - |